首頁 > 市場調查報告書 > 醫療設備

生技設備

細胞分離市場規模、佔有率和成長分析（按產品類型、細胞類型、細胞來源、技術、應用和地區分類）—2026-2033年產業預測

市場調查報告書

商品編碼

1899890

細胞分離市場規模、佔有率和成長分析（按產品類型、細胞類型、細胞來源、技術、應用和地區分類）—2026-2033年產業預測

Cell Isolation Market Size, Share, and Growth Analysis, By Product (Consumables, Instruments), By Cell Type (Human Cells, Animal Cells), By Cell Source, By Technique, By Application, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 188 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，細胞分離市場規模將達到 53.5 億美元，到 2025 年將達到 60.3 億美元，到 2033 年將達到 158.1 億美元，在預測期（2026-2033 年）內，複合年成長率為 12.8%。

細胞分離技術對於包括生物製藥開發、治療性蛋白質合成和研究分析在內的眾多應用至關重要。慢性疾病導致的醫療保健成本不斷攀升，以及政府推動生物技術發展的舉措，正推動對先進細胞分離技術的需求激增。 NanoString Technologies、Levitas Bio 和 Bionano Genomics 等公司正在擴展其生產流程和產品線以滿足此需求。近期技術進步使得針對特定應用篩選高性能細胞成為可能，有助於提升研究成果。生物製藥的興起和對醫療創新日益成長的關注，反映了旨在最佳化研究和治療方法的市場趨勢，進一步推動了對先進細胞分離設備的需求。這一趨勢為該領域帶來了強勁的成長機會。

細胞分離市場促進因素

細胞分離市場的發展主要受慢性疾病（尤其是癌症）發生率上升的推動。全球癌症發生率的不斷攀升，導致對創新研究和治療方案的需求日益成長。細胞分離技術在癌症研究中至關重要，它使科學家能夠分析不同類型的細胞，從而促進標靶治療和個人化醫療的開發。細胞分離技術使研究人員能夠深入了解腫瘤生物學、抗藥性和免疫反應，進而設計出更有效的治療方法。此外，對包括免疫療法在內的先進治療方法的需求不斷成長，也進一步推動了對細胞分離技術的需求，進而促進了研究機構、生物技術和製藥公司的發展和創新。

限制細胞分離市場發展的因素

細胞分離市場面臨的主要挑戰之一是，分離特定細胞類型所需的專用設備和技術需要大量的資金投入。流式細胞儀、離心機和磁激活細胞分選（MACS）系統等先進工具的高成本，使得許多小規模研究機構和實驗室難以採用。此外，試劑的持續支出以及對高素質人員的需求，都會增加整體經濟負擔，從而可能阻礙先進細胞分離方法的應用，並限制該領域的研發機會。

細胞分離市場趨勢

細胞分離市場正經歷著向微流控技術大規模應用的重大轉變。此技術透過微小通道操控微量流體，能夠根據細胞的大小和形狀等獨特屬性進行精確分離。這顯著提高了從複雜生物基質中分離稀有細胞類型（包括循環性腫瘤細胞和幹細胞）的效率。微流體技術具有精度和效率更高、試劑消費量更少、成本效益高等優勢，使其成為科學研究和臨床應用領域極具吸引力的解決方案，並推動其在醫療和生物技術領域的廣泛應用。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲（MEA）
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭格局

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市集活動
主要企業市佔率（2025 年）

主要企業簡介

Danaher Corporation（US）
Merck KGAA（Germany）
Thermo Fisher Scientific Inc.（US）
BD（Becton, Dickinson and Company）（US）
Sartorius AG（Germany）
Agilent Technologies, Inc.（US）
Bio-Rad Laboratories, Inc.（US）
Qiagen（Netherlands）
F. Hoffmann-La Roche Ltd.（Switzerland）
Revvity（US）
Lonza（Switzerland）
Bio-Techne（US）
Terumo Corporation（Japan）
Miltenyi Biotec（Germany）
Takara Bio Inc.（Japan）
Genscript（China）
Standard Biotools（US）
Alfa Laval（Sweden）
Promega Corporation（US）
Cell Signaling Technology, Inc.（US）
Micareo Inc.（US）
Applied Cells Inc.（US）
Stemcell Technologies（Canada）
Creative Bioarray（US）
Proteintech Group, Inc.（US）
Magbio Genomics, Inc.（US）
Akadeum Life Sciences（US）
Pluriselect Life Science Ug（Haftungsbeschrankt）& Co. KG（Germany）
Invent Biotechnologies, Inc.（US）

簡介目錄

Product Code: SQMIG35H2298

Cell Isolation Market size was valued at USD 5.35 Billion in 2024 and is poised to grow from USD 6.03 Billion in 2025 to USD 15.81 Billion by 2033, growing at a CAGR of 12.8% during the forecast period (2026-2033).

Cell isolation is pivotal across a spectrum of applications, including biologics development, therapeutic protein synthesis, and research analysis. As healthcare costs rise due to chronic diseases, coupled with government initiatives aimed at boosting biotechnology, the demand for advanced cell isolation techniques is surging. Companies like NanoString Technologies, Levitas Bio, and Bionano Genomics have expanded their manufacturing processes and product lines to meet this demand. Recent innovations allow for the selection of high-performing cells for targeted applications, enhancing research outcomes. The rise of biopharmaceuticals and increased focus on healthcare innovation further drive the need for advanced cell isolation equipment, reflecting a growing trend in the market that seeks to optimize research and treatment methodologies. This trend indicates a robust opportunity for growth within the sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cell Isolation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cell Isolation Market Segments Analysis

Global Cell Isolation Market is segmented by Product, Cell Type, Cell Source, Technique, Application, End User, and region. Based on Product, the market is segmented into Consumables, and Instruments. Based on Cell Type, the market is segmented into Human Cells, and Animal Cells. Based on Cell Source, the market is segmented into Adipose Tissue, Bone Marrow, Cord Blood/Embryonic Stem Cells, and Other Cell Sources. Based on Technique, the market is segmented into Centrifugation-Based Cell Isolation, Surface Marker-Based Cell Isolation, and Filtration-Based Cell Isolation. Based on Application, the market is segmented into Biomolecule Isolation, Cancer Research,Stem CellResearch, Tissue, Regeneration & Regenerative Medicine, In Vitro Diagnostics, and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Laboratories, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Cell Isolation Market

The cell isolation market is significantly driven by the rising incidence of chronic diseases, particularly cancer. As cancer rates escalate globally, the need for innovative research and treatment solutions intensifies. Cell isolation is crucial in cancer research, allowing scientists to examine distinct cell types, which facilitates the creation of targeted therapies and personalized medicine. By isolating cells, researchers gain vital insights into tumor biology, drug resistance, and immune responses, leading to the design of more effective treatments. Additionally, the growing demand for advanced therapies, including immunotherapy, further fuels the need for cell isolation techniques, driving growth and innovation across research institutions, biotech firms, and pharmaceutical companies.

Restraints in the Cell Isolation Market

One of the primary challenges facing the cell isolation market is the significant financial investment required for the specialized equipment and technologies necessary for isolating specific cell types. The high costs associated with advanced tools like flow cytometers, centrifuges, and magnetic-activated cell sorting (MACS) systems can deter many small research institutions and laboratories from acquiring them. Additionally, the ongoing expenses for reagents and the need for highly trained personnel further contribute to the overall financial strain, which may hinder the adoption of sophisticated cell isolation methods and limit research and development opportunities in this field.

Market Trends of the Cell Isolation Market

The cell isolation market is witnessing a significant shift towards the large-scale application of microfluidics technology, characterized by the manipulation of tiny fluid volumes through microchannels. This innovative approach allows for the precise separation of cells based on distinct characteristics such as size and shape, enhancing the isolation of rare cell types from complex biological matrices, including circulating tumor cells and stem cells. The advantages of microfluidics, including improved accuracy and efficiency, coupled with reduced reagent consumption and cost-effectiveness, position it as a highly attractive solution for both research and clinical applications, thereby driving its adoption across the healthcare and biotechnology sectors.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Technology Analysis
Pricing Analysis
Value Chain Analysis
Patent Analysis
Supply Chain Analysis
Regulatory Landscape
Customer & Buying Criteria Analysis

Cell Isolation Market by Product

Market Overview
Consumables
- Reagents, Kits, Media, And Sera
- Beads
- Magnetic Beads
- Fluorescent Beads
- Disposables
Instruments
- Centrifuges
- Cell Sorters
- Magnetic-Activated Cell Separator Systems
- Filtration Systems

Cell Isolation Market by Cell Type

Market Overview
Human Cells
- Differentiated Cells
- Stem Cells
Animal Cells

Cell Isolation Market by Cell Source

Market Overview
Adipose Tissue
Bone Marrow
Cord Blood/Embryonic Stem Cells
Other Cell Sources

Cell Isolation Market by Technique

Market Overview
Centrifugation-Based Cell Isolation
Surface Marker-Based Cell Isolation
Filtration-Based Cell Isolation

Cell Isolation Market by Application

Market Overview
Biomolecule Isolation
Cancer Research
Stem Cell Research
Tissue Regeneration & Regenerative Medicine
In Vitro Diagnostics
Other Applications

Cell Isolation Market by End User

Market Overview
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Hospitals & Diagnostic Laboratories
Other End Users

Cell Isolation Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGAA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (Becton, Dickinson and Company) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revvity (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genscript (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Standard Biotools (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alfa Laval (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cell Signaling Technology, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Micareo Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Applied Cells Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stemcell Technologies (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Bioarray (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Proteintech Group, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Magbio Genomics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Akadeum Life Sciences (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pluriselect Life Science Ug (Haftungsbeschrankt) & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Invent Biotechnologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments